These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34472901)

  • 1. The relationship of cogniphobia to performance validity and symptom validity in neuropsychological assessment.
    Lee GJ; Suhr J; Henry GK; Heilbronner RL; Drane DL
    Neuropsychology; 2021 Oct; 35(7):762-769. PubMed ID: 34472901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance validity and symptom validity tests: Are they measuring different constructs?
    Ord AS; Shura RD; Sansone AR; Martindale SL; Taber KH; Rowland JA
    Neuropsychology; 2021 Mar; 35(3):241-251. PubMed ID: 33829824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 4. Cogniphobia and neuropsychological functioning in migraine.
    Klepper JE; Sebrow L; Rosen NL; Seng EK
    Neuropsychology; 2022 Jul; 36(5):433-442. PubMed ID: 35389723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of informant report interpretations: Role of examinee performance and symptom invalidity.
    Webber TA; Sullivan-Baca E; Modiano YA; Taiwo Z; Grabyan JM
    Psychol Assess; 2022 Feb; 34(2):125-138. PubMed ID: 34647761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cogniphobia in Mild Traumatic Brain Injury.
    Silverberg ND; Iverson GL; Panenka W
    J Neurotrauma; 2017 Jul; 34(13):2141-2146. PubMed ID: 28114873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain-related fear is associated with cognitive task avoidance: exploration of the cogniphobia construct in a recurrent headache sample.
    Suhr J; Spickard B
    Clin Neuropsychol; 2012; 26(7):1128-41. PubMed ID: 22928643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Types or modes of malingering? A confirmatory factor analysis of performance and symptom validity tests.
    Egeland J; Andersson S; Sundseth ØØ; Schanke AK
    Appl Neuropsychol Adult; 2015; 22(3):215-26. PubMed ID: 25275555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of assessing for validity of symptom report and performance in attention deficit/hyperactivity disorder (ADHD): Introduction to the special section on noncredible presentation in ADHD.
    Suhr JA; Berry DTR
    Psychol Assess; 2017 Dec; 29(12):1427-1428. PubMed ID: 29227123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. German language adaptation of the Cogniphobia Scale for Headache Disorders (CS-HD) and development of a new short form (CS-HD-6).
    Klan T; Bräscher AK; Seng EK; Gaul C; Witthöft M
    Headache; 2024; 64(7):772-782. PubMed ID: 38785395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive utility of neuropsychological symptom validity testing as it relates to psychological presentation.
    Zakzanis KK; Gammada E; Jeffay E
    Appl Neuropsychol Adult; 2012; 19(2):98-107. PubMed ID: 23373576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs.
    An KY; Kaploun K; Erdodi LA; Abeare CA
    Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of the memory complaints inventory to detect invalid test performance.
    Armistead-Jehle P; Grills CE; Bieu RK; Kulas JF
    Clin Neuropsychol; 2016 May; 30(4):610-28. PubMed ID: 27117938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Cogniphobia Scale for Headache Disorders (CS-HD): A pilot study.
    Seng EK; Klepper JE
    Psychol Assess; 2017 Oct; 29(10):1296-1301. PubMed ID: 28125248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results.
    Richey LN; Doninger NA
    Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718
    [No Abstract]   [Full Text] [Related]  

  • 16. Illness Perceptions Predict Cognitive Performance Validity.
    Henry GK; Heilbronner RL; Suhr J; Gornbein J; Wagner E; Drane DL
    J Int Neuropsychol Soc; 2018 Aug; 24(7):735-745. PubMed ID: 29704907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective Cognitive Outcomes and Subjective Emotional Sequelae in Litigating Adults with a Traumatic Brain Injury: The Impact of Performance and Symptom Validity Measures.
    Uiterwijk D; Stargatt R; Crowe SF
    Arch Clin Neuropsychol; 2022 Nov; 37(8):1662-1687. PubMed ID: 35704852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of performance validity testing and symptom validity testing in psychoeducational assessment.
    Harrison AG; Beal AL; Armstrong IT
    Appl Neuropsychol Adult; 2023; 30(3):315-329. PubMed ID: 34261385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red flags in the clinical interview may forecast invalid neuropsychological testing.
    Keesler ME; McClung K; Meredith-Duliba T; Williams K; Swirsky-Sacchetti T
    Clin Neuropsychol; 2017 Apr; 31(3):619-631. PubMed ID: 27846775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.